Video Journal of Hematology & Hematological Oncology (VJHemOnc)

An action packed day 3 here at #ASH24! 🎥 🗞️🩸🇺🇸 Today we’ve spoken to: 🌟 Sanam Loghavi about all things #AMLsm 🌟 Omar Nadeem MD about exploring innovative therapies for high-risk smoldering myeloma and relapsed/refractory multiple myeloma 🌟 Julio Chavez MD on advances in #lymphoma care 🌟 Issa Khouri who spoke on adding inotuzumab ozogamicin to a melphalan + fludarabine redced-intensity conditioning regimen shows promise for allogeneic transplant in ALL and aggressive lymphoid malignancies 🌟 Shai Shimony on new insights in #AML and #BPDCN care 🌟 Jack Khouri, MD, FACP about an EASIX-based predictive model for ICANS & CRS after CAR-T therapy & Outcomes of teclistamab in pts with RRMM with prior exposure to BCMA-directed therapy 🌟 Enrique M. Ocio who discussed long-term efficacy and safety of isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) in newly diagnosed patients with #MultipleMyeloma patients not eligible for transplant or with no immediate transplant intent 🌟 Marina Konopleva who discussed innovative therapies presented at #ASH24 such as: tagraxofusp which shows promise in BPDCN with rapid hematopoiesis recovery & novel non-transplant options emerging for high-risk TP53 myeloid disease & many more! Stay tuned as we continue to share our exclusive coverage 👀 👉 https://lnkd.in/eBQtCaCs #Hematologynews #HemOnc

Join us for our Post-ASH 2024 #Myeloma Highlights!🔬🩸✨ 🗓️ 4 February 2025 📍Webinar 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Chair - Rakesh Popat 🌟 Moderators - Yi Lin and Elena Zamagni REGISTER NOW 👉 https://lnkd.in/eb33vBug Take a look at the agenda 👉 https://lnkd.in/eM2JqjFF #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

What an incredible year it's been🩸🧡✨ As 2024 comes to an end, we want to say a big thank you to our incredible audience and everyone who supports VJHemOnc.com - we couldn’t have done this without you 👏 We are especially grateful for all the world-leading #HemOnc experts who speak with us and those who provide editorial advice to help shape the content of our journals, allowing us to bring you relevant, cutting-edge and high quality scientific information 🧪 🎥🗞️ Here's to an even better 2025 ✨ Check out the latest congress coverage from #ASH, #ASCAT, #IMS & more 👉 https://lnkd.in/eMNM3PBt Or catch up on the latest in a disease area of your choice through our Disease Channels 👉 https://lnkd.in/eWdrCefk #HemOnc #LeuSM #LymSM #MMsm #MPNsm #MDSsm #AMLsm #CLLsm #ALLsm #Amyloidosis #ImmunoOnc

Watch as Irene Ghobrial, MD, Dana-Farber Cancer Institute dives into groundbreaking insights from longitudinal single-cell studies & #teclistamab outcomes at #ASH24 🎥 🩸💡 Don't miss this #VJHemOnc interview 👉 tinyurl.com/3u7dkrhn #MultipleMyeloma #MMsm #Hematologynews

Missed Key Moments at #ASH24? Fear not! We are hosting Post-ASH 2024 Highlights!🔬🩸✨ 🗓️ 23-7 February 2025 📍Webinar Series 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Prof. Barbara Eichhorst 🌟 Dr Rakesh Popat 🌟 Dr Amer Zeidan 🌟 Dr Wendy Osborne 🌟 Dr Naval Daver 🌟 Prof. Claire Harrison 🌟 Jorge Cortes REGISTER NOW 👉 https://lnkd.in/ekpmxeaz Take a look at the agendas 👉 https://lnkd.in/ds2_htjk #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

Want to hear about how the 5th iteration of the WHO’s classification system for #AML has changed the number of #genetically defined categories?🧬🩸 🎥 Then watch our interview from #ASH24 w/ the wonderful Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center 👉 https://ow.ly/qxSE50UsnuS #AMLsm #Leusm

New #Podcast Alert! 🎙️🚨 Advancing treatment for #BPDCN: current therapies, a deep dive into #tagraxofusp, & emerging novel agents🩸 🎧 Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center discusses: 💡 The challenges in treating this disease and reviews current therapeutic options such as #chemotherapy, #tagraxofusp, and #transplantation 💡The #CD123-targeted agent #tagraxofusp, addressing patient eligibility, the role of #tagraxofusp in bridging to #transplantation, and real-world data on its use 💡Insights into ongoing #clinicaltrials and emerging treatments for #BPDCN, including novel #CD123-#targetedtherapies, combination strategies, #BCL2inhibitors, and #immunotherapeutic approaches Tune in 👉 https://lnkd.in/eV3h_NSw Use the time codes to skip to your favourite part of each episode 👀 SUBSCRIBE so you don't miss any future episodes📱 #VJHemOnc #Hematologynews #MMsm

Join us for our Post-ASH 2024 #AML Highlights!🔬🩸✨ 🗓️ 31 January 2025 📍Webinar 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Chair - Naval Daver 🌟 Moderators - Charlie Craddock CBE, Jessica Altman & Univ.-Prof. Dr. med. Marion Subklewe REGISTER NOW 👉 https://lnkd.in/eFBbs63Q Take a look at the agenda 👉 https://lnkd.in/e6hFnubQ #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

Join us for our Post-ASH 2024 #CML Highlights!🔬🩸✨ 🗓️ 24 January 2025 📍Webinar 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Chair - Jorge Eduardo Cortes, MD 🌟 Moderators - Elisabetta Abruzzese & Mhairi Copland REGISTER NOW 👉 https://lnkd.in/eTGFqe-X Take a look at the agenda 👉 https://lnkd.in/ejrEBU9R #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

Spotlight on: Spotlight on: Prolonging #Remission In Patients With #AML 🗞️🩸 In this exclusive case study, hear from David Sallman, MD, Moffitt Cancer Center, who introduces a case featuring a 64-year-old male with #acutemyeloidleukemia (#AML) Dr Sallman discusses first-line treatment approaches, consolidation, and options for maintenance therapy, with the overall goal of prolonging remission in this patient 🔦 Take a look 👉 https://lnkd.in/eiwy4dSy #VJHemOnc #Leusm #Hematologynews